Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN) - A randomized controlled trial of therapeutic drug monitoring and adherence support

Saye H. Khoo, Judith Lloyd, Mark Dalton, Alec Bonington, Elizabeth Hart, Sara Gibbons, Peter Flegg, John Sweeney, Edmund G L Wilkins, David J. Back

    Research output: Contribution to journalArticlepeer-review

    Abstract

    We evaluated the feasibility and effectiveness of therapeutic drug monitoring (TDM) and adherence support (collectively, AT) vs standard of care (SOC) in patients receiving HIV protease inhibitors (PIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) within a nurse-led clinic. Primary end points were failure to achieve viral load of
    Original languageEnglish
    Pages (from-to)461-467
    Number of pages6
    JournalJournal of Acquired Immune Deficiency Syndromes
    Volume41
    Issue number4
    DOIs
    Publication statusPublished - Apr 2006

    Keywords

    • Adherence
    • HIV
    • Nonnucleoside reverse transcriptase inhibitors
    • Protease inhibitors
    • Therapeutic drug monitoring

    Fingerprint

    Dive into the research topics of 'Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN) - A randomized controlled trial of therapeutic drug monitoring and adherence support'. Together they form a unique fingerprint.

    Cite this